ZA935084B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA935084B
ZA935084B ZA935084A ZA935084A ZA935084B ZA 935084 B ZA935084 B ZA 935084B ZA 935084 A ZA935084 A ZA 935084A ZA 935084 A ZA935084 A ZA 935084A ZA 935084 B ZA935084 B ZA 935084B
Authority
ZA
South Africa
Prior art keywords
ethyl
pct
methylpropionyloxy
alpha
group
Prior art date
Application number
ZA935084A
Other languages
English (en)
Inventor
Robert Charles Hider
Surinder Singh
Gary Stuart Tilbrook
Paul Samuel Dobbin
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of ZA935084B publication Critical patent/ZA935084B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA935084A 1992-08-12 1993-07-14 Pharmaceutical compositions ZA935084B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929217099A GB9217099D0 (en) 1992-08-12 1992-08-12 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA935084B true ZA935084B (en) 1995-01-16

Family

ID=10720221

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935084A ZA935084B (en) 1992-08-12 1993-07-14 Pharmaceutical compositions

Country Status (10)

Country Link
US (1) US5480894A (de)
EP (1) EP0619808B1 (de)
JP (1) JPH07500120A (de)
AT (1) ATE173726T1 (de)
CA (1) CA2119020C (de)
DE (1) DE69322250T2 (de)
ES (1) ES2124307T3 (de)
GB (2) GB9217099D0 (de)
WO (1) WO1994004498A1 (de)
ZA (1) ZA935084B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2230564T3 (es) 1995-06-10 2005-05-01 Vitra Pharmaceuticals Ltd. Compuestos ferricos, composiciones, metodos de fabricacion de estos y sus utilizacioneds.
DE59611243D1 (de) * 1995-09-29 2005-08-11 Novartis Ag Hydroxypyridinone
US6767741B1 (en) 1999-08-27 2004-07-27 Invitrogen Corporation Metal binding compounds and their use in cell culture medium compositions
IL135884A (en) * 2000-04-30 2005-08-31 Yissum Res Dev Co Method for measuring non-transferrin bound iron
AU2001287850A1 (en) 2000-09-19 2002-04-02 Vitra Pharmaceuticals Limited Iron compositions
KR100863159B1 (ko) 2000-12-22 2008-10-13 에어 프로덕츠 앤드 케미칼스, 인코오포레이티드 산화 화합물 및 착물화 화합물을 함유하는 조성물
US6426418B1 (en) 2001-11-02 2002-07-30 Apotex, Inc. Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
WO2003065991A2 (en) 2002-02-05 2003-08-14 Bristol-Myers Squibb Company N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
EP2295980A1 (de) 2002-10-30 2011-03-16 Yissum Research Development Company, of The Hebrew University of Jerusalem Moleküle und diese verwendende Verfahren zur Messung von nicht-transferringebundenem Eisen
US7707255B2 (en) 2003-07-01 2010-04-27 Microsoft Corporation Automatic grouping of electronic mail
NZ529657A (en) 2003-11-20 2004-07-30 Apotex Inc Iron chelating cycloalkyl derivatives of 3-hydroxy-4-pyridinones
CA2488034C (en) * 2004-11-19 2009-10-06 Apotex Inc. Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
US9588781B2 (en) 2008-03-31 2017-03-07 Microsoft Technology Licensing, Llc Associating command surfaces with multiple active components
GB201007209D0 (en) 2010-04-29 2010-06-16 King S College London Compound
WO2012137202A1 (en) 2011-04-05 2012-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
DE102012007558A1 (de) 2012-04-14 2013-10-17 Alf Hammes Gabe substituierter bis-aryl-harnstoffderivate zur behandlung von anämien
GB201215675D0 (en) * 2012-09-03 2012-10-17 Univ Exeter Compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1074038B (it) * 1976-08-05 1985-04-17 Simes Esteri della epinina
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
EP0305646B1 (de) * 1983-03-24 1996-11-13 Btg International Limited 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen
US4908371A (en) * 1987-11-10 1990-03-13 Ciba-Geigy Corporation Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload
EP0335745A1 (de) * 1988-03-31 1989-10-04 The Royal Free Hospital School Of Medicine Verfahren zur Herstellung von Pyridin-4-onen
GB8910521D0 (en) * 1989-05-08 1989-06-21 Nat Res Dev The stabilization of organic compounds
GB9100465D0 (en) * 1991-01-09 1991-02-20 Hider Robert C Pharmaceutical compositions
GB9209078D0 (en) * 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions

Also Published As

Publication number Publication date
GB2269589B (en) 1996-06-26
ATE173726T1 (de) 1998-12-15
GB2269589A (en) 1994-02-16
ES2124307T3 (es) 1999-02-01
JPH07500120A (ja) 1995-01-05
DE69322250T2 (de) 1999-05-20
EP0619808A1 (de) 1994-10-19
GB9217099D0 (en) 1992-09-23
DE69322250D1 (de) 1999-01-07
EP0619808B1 (de) 1998-11-25
CA2119020A1 (en) 1994-03-03
US5480894A (en) 1996-01-02
WO1994004498A1 (en) 1994-03-03
GB9313557D0 (en) 1993-08-18
CA2119020C (en) 2003-12-16

Similar Documents

Publication Publication Date Title
GB2269589B (en) 3-Hydroxy-pyridin-4-ones and their use in pharmaceutical compositions
GR3017895T3 (en) New antiepileptic agents.
ATE184008T1 (de) Pyrrolopyridinderivate als dopaminrezeptor liganden
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
IL124966A0 (en) 1-indanyl- and 1-indanylidene-acetic derivatives
HU9303000D0 (en) Aryl-morpholine-derivatives and pharmaceutical compositions containing it and process for production thereof
ZA917597B (en) Pharmaceutical compositions
HUT65978A (en) Pharmaceutical compositions applicable for treatment of enteropathia and containing imidazol-1-yl-compounds
WO1994019025A3 (en) Contrast agents
HUT71523A (en) Gestagenically active 19,11-bridged 4-estrenes and pharmaceutical compositions containing the same
ATE155791T1 (de) Etoposid-derivate, ihre herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
ATE147755T1 (de) Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten
GR3025682T3 (en) Anti-inflammatory macrolactam (cyclamenol).
UA41376C2 (uk) ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ЛІКУВАННЯ АНДРОГЕННОЇ АЛОПЕЦІЇ ІНГІБІТОРАМИ 5-<font face="Symbol">a</font>-РЕДУКТАЗИ
ES2103232A1 (es) Nuevos compuestos derivados de 1h-imidazol-2-metanol.